Finance

Lists
HYL:EBR
Hyloris Pharmaceuticals SA
4,25 €
-0,70%
(-0,030) 1D
19-окт., 14:25:06 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HYL...
Open
4,11 €
High
4,25 €
Low
4,02 €
Mkt. cap
119,00 млн
Avg. vol.
5,76 миң
Volume
1,87 миң
52-wk high
8,40 €
52-wk low
3,38 €
EPS
-0,17 €
Shares outstanding
28,00 млн
No. of employees
54
Open
4,11 €
High
4,25 €
Low
4,02 €
Mkt. cap
119,00 млн
Avg. vol.
5,76 миң
Volume
1,87 миң
52-wk high
8,40 €
52-wk low
3,38 €
EPS
-0,17 €
Shares outstanding
28,00 млн
No. of employees
54
News stories
From web sources and news partners
About Hyloris Pharmaceuticals SA
CEOStijn Van Rompay
Employees54
Founded2012
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,30 млн
2,30 млн
2,61 млн
2,61 млн
Cost of goods sold
125,50 миң
125,50 миң
149,00 миң
149,00 миң
Cost of revenue
125,50 миң
125,50 миң
149,00 миң
149,00 миң
Research and development expenses
3,15 млн
3,15 млн
2,08 млн
2,08 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,34 млн
1,34 млн
1,26 млн
1,26 млн
Operating expense
4,49 млн
4,49 млн
3,17 млн
3,17 млн
Total operating expenses
4,61 млн
4,61 млн
3,32 млн
3,32 млн
Operating income
-2,31 млн
-2,31 млн
-707,00 миң
-707,00 миң
Other non operating income
87,00 миң
87,00 миң
-3,00 миң
-3,00 миң
EBT including unusual items
-1,50 млн
-1,50 млн
-937,50 миң
-937,50 миң
EBT excluding unusual items
-2,20 млн
-2,20 млн
-700,50 миң
-700,50 миң
Income tax expense
-106,00 миң
-106,00 миң
-
-
Effective tax rate
7,09%
7,09%
-
-
Other operating expenses
-6,50 миң
-6,50 миң
-173,50 миң
-173,50 миң
Net income
-1,39 млн
-1,39 млн
-937,50 миң
-937,50 миң
Net profit margin
-60,41%
-60,41%
-35,87%
-35,87%
Earnings per share
-
-
-
-
Interest and investment income
271,00 миң
271,00 миң
42,00 миң
42,00 миң
Interest expense
-14,00 миң
-14,00 миң
-21,50 миң
-21,50 миң
Net interest expenses
257,00 миң
257,00 миң
20,50 миң
20,50 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,00 млн
-2,00 млн
-518,50 миң
-518,50 миң
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору